Benutzer: Gast  Login
Titel:

Rationale for Surrogate Endpoints and Conditional Marketing Authorization of New Therapies for Kidney Transplantation.

Dokumenttyp:
Journal Article; Review
Autor(en):
Naesens, Maarten; Loupy, Alexandre; Hilbrands, Luuk; Oberbauer, Rainer; Bellini, Maria Irene; Glotz, Denis; Grinyó, Josep; Heemann, Uwe; Jochmans, Ina; Pengel, Liset; Reinders, Marlies; Schneeberger, Stefan; Budde, Klemens
Abstract:
Conditional marketing authorization (CMA) facilitates timely access to new drugs for illnesses with unmet clinical needs, such as late graft failure after kidney transplantation. Late graft failure remains a serious, burdensome, and life-threatening condition for recipients. This article has been developed from content prepared by members of a working group within the European Society for Organ Transplantation (ESOT) for a Broad Scientific Advice request, submitted by ESOT to the European Medici...     »
Zeitschriftentitel:
Transpl Int
Jahr:
2022
Band / Volume:
35
Volltext / DOI:
doi:10.3389/ti.2022.10137
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/35669977
Print-ISSN:
0934-0874
TUM Einrichtung:
Professur für Nephrologie (Prof. Heemann)
 BibTeX